Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc (INDV) Stock Overview

Explore Indivior Pharmaceuticals Inc’s financial performance, market position, analyst ratings, and future outlook.

INDV●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$40.45
$1.33(3.40%)
U.S. Market opens in 16h 20m

Indivior Pharmaceuticals Inc (INDV)

Meyka AI Score

Z

Key Financials

Market Cap5B
P/E Ratio19.83
EPS (TTM)$3.01
ROE-1.42%
Fundamental Analysis

AI Price Forecasts

1 Month$46.18
3 Months$49.63
1 Year Target$39.79

INDV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Indivior Pharmaceuticals Inc (INDV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $39.79.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.83 and a market capitalization of 5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.40%
5-Day Change
-1.61%
1-Month Change
5.56%
3-Month Change
25.50%
6-Month Change
22.65%
Year-to-Date (YTD) Change
12.74%
1-Year Change
159.29%
3-Year Change
67.63%
5-Year Change
292.72%
All-Time (Max) Change
279.81%

Contact Information

https://www.indivior.com
804 379 1090
10710 Midlothian Turnpike, North Chesterfield, VA, 23235

Company Facts

8,380 Employees
IPO DateDec 29, 2014
CountryUS
Actively Trading

Frequently Asked Questions